AGP Executive Report
Last update: 9 hours agoPublic Health: The U.S. has lost its measles-elimination status after sustained transmission, according to global health authorities. Two doses of the MMR vaccine prevent about 97% of infections. Pharma Investment: Eli Lilly is eyeing a $1 billion investment in Hyderabad, as India courts global drugmakers. Healthcare Costs: India’s government health spending more than tripled to ₹4.14 lakh crore in 2023–24, while households’ share of costs paid out of pocket fell to 42.7%, down from 64.2% a decade earlier. GLP-1 Care: Cleveland Clinic researchers found patients who stopped weight-loss injections did better when they moved to another treatment; those receiving no further care had the least weight loss and improvement in blood sugar and blood pressure. The FDA is also requiring updated safety information on semaglutide medicines after a potential link to a rare vision condition. Early Intervention: AC Health is backing a Valenzuela program offering developmental support for children from birth to age five.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.